Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Companies
  3. drug designation
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Downloads
Videos

Refine by
Locations

  • USA
  • Canada
  • Europe

  • Africa
  • Asia & Middle East
  • Australasia
  • Latin America
  • North America
Business Types

  • Manufacturer
  • Technology
  • Service provider
  • Software vendor
  • Training provider
  • Laboratory
Industries served

  • Medical / Health Care
  • Chemical & Pharmaceuticals
  • University / Academia / Research
  • Agriculture
  • Monitoring and Testing
  • Environmental
  • Health and Safety
Employees

  • 11-100

Drug Designation Suppliers & Manufacturers

81 companies found

AdAlta Limited

AdAlta Limited

based inBundoora, AUSTRALIA
AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...
Lungs - Idiopathic Pulmonary Fibrosis (IPF)

Lungs - Idiopathic Pulmonary Fibrosis (IPF)

A specific form of lung fibrosis is Idiopathic pulmonary fibrosis (IPF), which is a chronic and ultimately fatal disease, where tissue deep in the lungs becomes scarred, over time, resulting in a progressive decline in lung function and shortness of ...
CONTACT SUPPLIER

Daiichi Sankyo Company Limited

Daiichi Sankyo Company Limited

based inTokyo, JAPAN
Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. We provide innovative products and services in 29 countries/regions around the world. With more than 120 years of scientific expertise, our company draws upon a rich ...
TURALIO - Oral Small Molecule

TURALIO - Oral Small Molecule

TURALIO (pexidartinib) is an oral small molecule that targets colony stimulating factor 1 receptor (CSF1R), KIT proto-oncogene receptor tyrosine kinase (KIT), and FMS-like tyrosine kinase 3 (FLT3) harboring an internal tandem duplication (ITD) ...
CONTACT SUPPLIER

Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics, Inc.

based inCarlsbad, CALIFORNIA (USA)
Our mission is to pioneer a new branch of medicine based on transplanting specific cell types to patients with serious medical conditions. Lineage’s programs are based on the Company’s proprietary cell-based therapy platform and associated ...
Model OPC1 - Oligodendrocyte Progenitor Cell Therapy for Spinal Cord Injury

Model OPC1 - Oligodendrocyte Progenitor Cell Therapy for Spinal Cord Injury

OPC1 is an oligodendrocyte progenitor cell therapy that is currently in a Phase 1/2a multicenter clinical trial for acute spinal cord injuries (SCI). Oligodendrocyte progenitor cells (OPCs) are naturally-occurring precursors to the cells which ...
CONTACT SUPPLIER

Ariana Pharma

Ariana Pharma

based inParis, FRANCE
Ariana Pharma is a leading Al driven Precision Medicine Company focused on accelerating clinical drug development and designing advanced therapeutic decision support systems. Using its KEM Explainable Artificial Intelligence (XAl) technology, Ariana ...
CONTACT SUPPLIER

MedChemExpress LLC (MCE)

MedChemExpress LLC (MCE)

based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
MedChemExpress - Model Crizotinib-d5 - 1395950-84-1

MedChemExpress - Model Crizotinib-d5 - 1395950-84-1

Crizotinib-d5 is the deuterium labeled Crizotinib. Crizotinib (PF-02341066) is an orally bioavailable, ATP-competitive ALK and c-Met inhibitor with IC50s of 20 and 8 nM, respectively. Crizotinib inhibits tyrosine phosphorylation of NPM-ALK and ...
CONTACT SUPPLIER

Immune-Onc Therapeutics, Inc.

Immune-Onc Therapeutics, Inc.

based inPalo Alto, CALIFORNIA (USA)
Immune-Onc is a clinical-stage company developing a novel class of myeloid checkpoint inhibitors. We believe myeloid checkpoints are the next frontier of immunotherapy for cancer. In collaboration with scientists, our research team is among the ...
Immune-Onc - Model IO-202 - (Anti-LILRB4) Mechanisms of Action in Hematologic Malignancies Program

Immune-Onc - Model IO-202 - (Anti-LILRB4) Mechanisms of Action in Hematologic Malignancies Program

Immune-Onc’s lead program is IO-202, an antagonist antibody targeting the myeloid checkpoint LILRB4 (also known as ILT3). Immune-Onc has a Phase I trial underway to evaluate IO-202 as a potential treatment for acute myeloid leukemia (AML) and ...
CONTACT SUPPLIER

RASA Life Science Informatics

RASA Life Science Informatics

based inPune, INDIA
RASA Life Science Informatics, a highly-regarded organization, has gained recognition from Biotech Consortium India Limited (BCIL) and is based in Pune, India. They not only provide research and development services but also offer a comprehensive ...
Biotechnology Dissertation Training Program

Biotechnology Dissertation Training Program

RASA has designed the Industrial Biotechnology Dissertation program specially for students who are doing their Biotechnology final year project And Bioinformatics Thesis for Bsc, Msc, Btech or Mtech. The idea behind this is to give the students ...
CONTACT SUPPLIER

Alkahest, Inc.

Alkahest, Inc.

based inSan Carlos, CALIFORNIA (USA)
Alkahest is a clinical stage biopharmaceutical company targeting neurodegenerative and age-related diseases with transformative therapies derived from a deep understanding of the plasma proteome in aging and ...
Alkahest - Model AKST4290 - Targeting Eotaxin Cell

Alkahest - Model AKST4290 - Targeting Eotaxin Cell

One the key chronokine targets identified using Alkahest’s platform is eotaxin. Eotaxin is an immunomodulatory chemokine that is increased in normal aging as well as multiple diseases of aging. It has been implicated in Alzheimer’s ...
CONTACT SUPPLIER

MiTeGen

MiTeGen

based inIthaca, NEW YORK (USA)
MiTeGen designs, manufactures and distributes products for cryo-em (cryo electron microscopy), crystallization, crystallography and X-ray diffraction of proteins, viruses and small molecule/inorganic compounds, and for manipulation and measurement ...
CONTACT SUPPLIER

Alfa Chemistry

Alfa Chemistry

based inNY, NEW YORK (USA)
As a global Contract Research Organization (CRO), headquartered in New York, USA, Alfa Chemistry has served the pharmaceutical and biotechnology industries for years. Today, Alfa Chemistry is specialized in organic chemistry, material chemistry, and ...
Alfa - Difluoromethyl Heterocyclic Fluorinated Building Blocks

Alfa - Difluoromethyl Heterocyclic Fluorinated Building Blocks

Introducing fluorine atom(s) into bioactive organic compounds has become a leading strategy for drug design and lead optimization. In drug synthesis strategy, fluorine is frequently employed to ...
CONTACT SUPPLIER

Galera Therapeutics, Inc.

Galera Therapeutics, Inc.

based inMalvern, PENNSYLVANIA (USA)
We are a clinical stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer. We leverage our expertise in superoxide dismutase ...
CONTACT SUPPLIER

Azafaros

Azafaros

based inNaarden, NETHERLANDS
Azafaros has leveraged on decades of discovery by professors Hans Aerts, Hermen Overkleeft, and Stan van Boeckel at Leiden University and the Academic Medical Center in the Netherlands. Expanding on their research and led by highly experienced ...
Oral Treatment for Lysosomal Storage Disorders

Oral Treatment for Lysosomal Storage Disorders

Oral administration allows for home-based, lifelong treatment, enhancing quality of life, particularly for pediatric patients, and reducing dependency on gene or enzyme replacement therapies. The U.S. FDA's Orphan Drug ...
CONTACT SUPPLIER

InterX

InterX

based inBerkeley, CALIFORNIA (USA)
InterX, led by Nobel Prize-winning scientists, is developing tools for pharmaceutical ligand design, material science, and biochemistry. We leverage our proprietary software tools for internal molecule development work, as well as joint ventures. ...
Proprietary Software for Development Division

Proprietary Software for Development Division

InterX Development Division focuses on bridging the risk gap in Drug Discovery from drug targets to novel candidates. The Development Division applies InterX’s proprietary computer-aided drug ...
CONTACT SUPPLIER

Biosensors International Group, Ltd.

Biosensors International Group, Ltd.

based inSingapore, SINGAPORE
For more than 25 years, the Biosensors International Group (“Biosensors”) has been developing and marketing critical care catheter systems and related devices used during heart surgery and intensive care treatment. Continually striving to be at the ...
CONTACT SUPPLIER

Lung Therapeutics, Inc.

Lung Therapeutics, Inc.

based inAustin, TEXAS (USA)
Headquartered in Austin, Texas, Lung Therapeutics, Inc. is a clinical stage biopharmaceutical company formed to leverage decades of leading research in orphan, pulmonary indications for which there are unmet medical needs. The company is developing ...
Lung Therapeutics - Model LTI-01 - First-in-Class Treatment for Loculated Pleural Effusion (LPE)

Lung Therapeutics - Model LTI-01 - First-in-Class Treatment for Loculated Pleural Effusion (LPE)

A pleural effusion is defined by the build-up of fluid in the pleural cavity, predominantly resulting from pneumonia. A loculated pleural effusion (LPE) occurs when scar tissue forms in the pleural cavity, trapping the fluid and preventing ...
CONTACT SUPPLIER

Zymeworks Inc

Zymeworks Inc

based inVancouver, BRITISH COLUMBIA (CANADA)
Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of ...
Zanidatamab - Bispecific Antibody

Zanidatamab - Bispecific Antibody

Zymeworks’ lead product candidate, zanidatamab, is a HER2-targeted bispecific antibody developed using Zymeworks proprietary Azymetric platform. Zanidatamab is currently being evaluated in global Phase 1, Phase 2 and pivotal clinical trials as ...
CONTACT SUPPLIER

Lumencor

Lumencor

based inBeaverton, OREGON (USA)
Lumencor provides innovative light engine solutions tailored for a variety of advanced imaging applications within the scientific and industrial communities. Their portfolio includes products such as the ZIVA Light Engine, which integrates ...
CONTACT SUPPLIER

RedHill Biopharma Ltd.

RedHill Biopharma Ltd.

based inTel-Aviv, ISRAEL
RedHill Biopharma (NASDAQ: RDHL) is driven to develop extraordinary medicines for people to live extraordinary lives. RedHill applies innovation, focus and a collective mindset of delivering on our promises, to build a company at the forefront of ...
Opaganib - Model ABC294640 - Anti-Inflammatory and Anti-Viral Tablets

Opaganib - Model ABC294640 - Anti-Inflammatory and Anti-Viral Tablets

Opaganib (ABC294640) is a first-in-class, proprietary sphingosine kinase-2 (SK2) selective inhibitor, administered orally, with anticancer, anti-inflammatory and anti-viral ...
CONTACT SUPPLIER

Ainnocence Inc.

Ainnocence Inc.

based inSacramento, CALIFORNIA (USA)
Ainnocence is a next-generation biotech aiming to create a self-evolving modularized intelligent platform that integrates various advanced computational and wet lab technologies to revolutionize the drug discovery and development process. We ...
CarbonAI - Small Molecule Drug Design Services

CarbonAI - Small Molecule Drug Design Services

Simple : CarbonAI searches over 1.9 billion compounds to create synthesizable drug candidates – based only on target sequence. Precise : CarbonAI accurately identifies the most active and safe compound with a multi-objective optimization ...
CONTACT SUPPLIER

ENB Therapeutics

ENB Therapeutics

based inNew York, NEW YORK (USA)
ENB is developing platform oncology molecules to unlock the full therapeutic potential of immune-based cancer therapies. We are developing small molecules that turn off a common “switch” that activates critical pro-cancer components of the TME: the ...
ENB - Model ENB003 - Potential Synergy with Multiple Immuno-oncology Platforms

ENB - Model ENB003 - Potential Synergy with Multiple Immuno-oncology Platforms

ETBR on the luminal surface of tumor blood vessels, creates a barrier to transendothelial migration and homing of T-cells from the vessel to the tumor by downregulating ICAM-1 (an adhesion molecule). ETBRI blockers restore ICAM-1 expression which ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT